Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)
Clinical trial NCT05277480 · COMPLETED
Trial details
- NCT number
- NCT05277480
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-06-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.